| __timestamp | Cytokinetics, Incorporated | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 1860000 |
| Thursday, January 1, 2015 | 19667000 | 2963000 |
| Friday, January 1, 2016 | 27823000 | 6961000 |
| Sunday, January 1, 2017 | 36468000 | 11779000 |
| Monday, January 1, 2018 | 31282000 | 13697000 |
| Tuesday, January 1, 2019 | 39610000 | 15749000 |
| Wednesday, January 1, 2020 | 52820000 | 18638000 |
| Friday, January 1, 2021 | 96803000 | 27196000 |
| Saturday, January 1, 2022 | 177977000 | 31739000 |
| Sunday, January 1, 2023 | 173612000 | 33491000 |
Unleashing the power of data
In the dynamic world of biotechnology, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent biotech companies: Cytokinetics, Incorporated and Protagonist Therapeutics, Inc., from 2014 to 2023.
Cytokinetics has seen a remarkable increase in SG&A expenses, growing over 900% from 2014 to 2023. This surge reflects their aggressive expansion and investment in research and development. In contrast, Protagonist Therapeutics experienced a more modest rise of approximately 1,700% over the same period, indicating a steady yet cautious approach to scaling operations.
The data reveals a pivotal trend: while both companies are investing heavily in their administrative capabilities, Cytokinetics is leading the charge with a more pronounced financial commitment. This insight underscores the diverse strategies employed by biotech firms in navigating the competitive landscape.
AbbVie Inc. and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Cytokinetics, Incorporated
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Protagonist Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Genmab A/S or Cytokinetics, Incorporated
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.: SG&A Expense Trends
Viking Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?